Summary
Ependymomas, which comprise 5% of central nervous system tumors, have not been extensively characterized genetically. The p53 tumor suppressor gene is frequently mutated in human cancer, and is important in the pathogenesis of other central nervous system (CNS) tumors. Chromosomal DNA corresponding to the p53 tumor suppressor gene was amplified by the polymerase chain reaction (PCR) from 31 archival ependymoma specimens. DNA was screened for the presence of p53 mutations by single strand conformational polymorphism (SSCP) analysis; samples with altered mobility were further tested for the presence of mutation by direct DNA sequence analysis. Of the 31 ependymomas tested, one contained a detectable DNA sequence change in the p53 gene. Sequencing revealed a silent mutation in exon 6, at codon 213, which represents a known p53 sequence polymorphism. These findings suggest that in contrast to many other human cancers, p53 mutation is not important in the pathogenesis or progression of ependymomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stratton MR, Darling J, Lantos PL, Cooper CS, Reeves BR: Cytogenetic abnormalities in human ependymomas. Int J Cancer 44: 579–581, 1989
Sawyer JR, Crowson ML, Roloson GJ, Chadduck WM: Involvement of the short arm of chromosome 1 in a myxopapillary ependymoma. Cancer Genet Cytogenet 54: 55–60, 1991
Lyons MK, Kelly PJ: Posterior fossa ependymomas: Report of 30 cases and review of the literature. Neurosurg 28: 659–665, 1991
Goldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L, D'Angio GJ: Recurrent intracranial ependymomas in children: Survival, patterns of failure, and prognostic factors. Cancer 66: 557–563, 1990
Ross GW, Rubinstein LJ: Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31–36, 1989
Rawlings III CE, Giangaspero F, Burger PC, Bullard DE: Ependymomas: A clinicopathologic study. Surg Neurol 29: 271–281, 1988
Mork SJ, Loken AC: Ependymoma: A follow up study of 101 cases. Cancer 40: 907–915, 1975
Thiel G, Losanowa T, Kintzel D, Nisch G, Martin H, Vorpahl K, Witkowski R: Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58: 109–120, 1992
Rasheed BKA, Bigner SH: Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 10: 289–299, 1991
Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF: Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66: 106–112, 1992
Bown NP, Pearson ADJ, Davison EV, Gardner-Medwin D, Crawford P, Perry R: Multiple chromosome rearrangements in a childhood ependymoma. Cancer Genet Cytogenet 36: 25–30, 1988
James CD, He J, Carlbom E, Mikkelsen T, Ridderheim PA: Loss of genetic information in central nervous system tumors common to children and young adults. Genes, Chromosomes Cancer 2: 94–102, 1990
Griffin CA, Long PP, Carson BS, Brem H: Chromosome abnormalities in low-grade central nervous system tumors. Cancer Genet Cytogenet 60: 67–73, 1992
Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB: Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes, Chromosomes Cancer 5: 348–356, 1992
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–53, 1991
Vogelstein B: Cancer: A deadly inheritance. Nature 348: 681–682, 1990
Kyristis AP, Saya H: Epidemiology, cytogenetics and molecular biology of brain tumors. Current Opin Oncol 5: 474–480, 1993
Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846–847, 1992
Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC: A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3: 229–235, 1993
Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202–6205, 1991
Saylors III RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721–4723, 1991
Sarkar FH, Kupsky WJ, Li YW, Sreepathi P: Analysis of p53 gene mutations in human gliomas by polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Diagnostic Molec Pathol 3: 2–8, 1994
Waber PG, Chen J, Nisen PD: Infrequency of ras, p53, WT1 or RB gene alterations in Wilms tumors. Cancer 72: 3732–3738, 1993
Welter C, Henn W, Theisinger B, Fischer H, Zang KD, Blin N: The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. Cancer Lett 52: 57–62, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fink, K.L., Rushing, E.J., Schold, S.C. et al. Infrequency of p53 gene mutations in ependymomas. J Neuro-Oncol 27, 111–115 (1996). https://doi.org/10.1007/BF00177473
Issue Date:
DOI: https://doi.org/10.1007/BF00177473